Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Supplemental material
  • Version history
  • Article usage
  • Citations to this article
Advertisement

Clinical Research and Public HealthIn-Press PreviewClinical ResearchReproductive biology Open Access | 10.1172/jci.insight.202443

Programmed cycle-induced endometrial perturbations do not independently influence angiogenic imbalance or hypertensive disorders in pregnancy

David Huang,1 Emily Flynn,2 Brittany R. Davidson,2 Juan C. Irwin,3 Mohammad Naser,2 Ana Laura Almonte,4 Jennifer Qin,5 Yue Song,5 Fleurdeliza B. Rabara,1 Rebecca Wong,1 Lydia B. Zablotska,6 Mitchell P. Rosen,1 Torsten Wittmann,2 Gabriela K. Fragiadakis,2 Alexis J. Combes,2 Marina Sirota,4 Marcelle I. Cedars,1 and Linda C. Giudice1

1Division of Reproductive Endocrinology & Infertility, Department of Obstetr, UCSF, San Francisco, United States of America

2CoLabs, UCSF, San Francisco, United States of America

3Center for Reproductive Sciences, UCSF, San Francisco, United States of America

4Bakar Computational Health Sciences Institute, UCSF, San Francisco, United States of America

5Department of Obstetrics, Gynecology & Reproductive Sciences, UCSF, San Francisco, United States of America

6Department of Epidemiology and Biostatistics, UCSF, San Francisco, United States of America

Find articles by Huang, D. in: PubMed | Google Scholar

1Division of Reproductive Endocrinology & Infertility, Department of Obstetr, UCSF, San Francisco, United States of America

2CoLabs, UCSF, San Francisco, United States of America

3Center for Reproductive Sciences, UCSF, San Francisco, United States of America

4Bakar Computational Health Sciences Institute, UCSF, San Francisco, United States of America

5Department of Obstetrics, Gynecology & Reproductive Sciences, UCSF, San Francisco, United States of America

6Department of Epidemiology and Biostatistics, UCSF, San Francisco, United States of America

Find articles by Flynn, E. in: PubMed | Google Scholar

1Division of Reproductive Endocrinology & Infertility, Department of Obstetr, UCSF, San Francisco, United States of America

2CoLabs, UCSF, San Francisco, United States of America

3Center for Reproductive Sciences, UCSF, San Francisco, United States of America

4Bakar Computational Health Sciences Institute, UCSF, San Francisco, United States of America

5Department of Obstetrics, Gynecology & Reproductive Sciences, UCSF, San Francisco, United States of America

6Department of Epidemiology and Biostatistics, UCSF, San Francisco, United States of America

Find articles by Davidson, B. in: PubMed | Google Scholar

1Division of Reproductive Endocrinology & Infertility, Department of Obstetr, UCSF, San Francisco, United States of America

2CoLabs, UCSF, San Francisco, United States of America

3Center for Reproductive Sciences, UCSF, San Francisco, United States of America

4Bakar Computational Health Sciences Institute, UCSF, San Francisco, United States of America

5Department of Obstetrics, Gynecology & Reproductive Sciences, UCSF, San Francisco, United States of America

6Department of Epidemiology and Biostatistics, UCSF, San Francisco, United States of America

Find articles by Irwin, J. in: PubMed | Google Scholar

1Division of Reproductive Endocrinology & Infertility, Department of Obstetr, UCSF, San Francisco, United States of America

2CoLabs, UCSF, San Francisco, United States of America

3Center for Reproductive Sciences, UCSF, San Francisco, United States of America

4Bakar Computational Health Sciences Institute, UCSF, San Francisco, United States of America

5Department of Obstetrics, Gynecology & Reproductive Sciences, UCSF, San Francisco, United States of America

6Department of Epidemiology and Biostatistics, UCSF, San Francisco, United States of America

Find articles by Naser, M. in: PubMed | Google Scholar

1Division of Reproductive Endocrinology & Infertility, Department of Obstetr, UCSF, San Francisco, United States of America

2CoLabs, UCSF, San Francisco, United States of America

3Center for Reproductive Sciences, UCSF, San Francisco, United States of America

4Bakar Computational Health Sciences Institute, UCSF, San Francisco, United States of America

5Department of Obstetrics, Gynecology & Reproductive Sciences, UCSF, San Francisco, United States of America

6Department of Epidemiology and Biostatistics, UCSF, San Francisco, United States of America

Find articles by Almonte, A. in: PubMed | Google Scholar

1Division of Reproductive Endocrinology & Infertility, Department of Obstetr, UCSF, San Francisco, United States of America

2CoLabs, UCSF, San Francisco, United States of America

3Center for Reproductive Sciences, UCSF, San Francisco, United States of America

4Bakar Computational Health Sciences Institute, UCSF, San Francisco, United States of America

5Department of Obstetrics, Gynecology & Reproductive Sciences, UCSF, San Francisco, United States of America

6Department of Epidemiology and Biostatistics, UCSF, San Francisco, United States of America

Find articles by Qin, J. in: PubMed | Google Scholar

1Division of Reproductive Endocrinology & Infertility, Department of Obstetr, UCSF, San Francisco, United States of America

2CoLabs, UCSF, San Francisco, United States of America

3Center for Reproductive Sciences, UCSF, San Francisco, United States of America

4Bakar Computational Health Sciences Institute, UCSF, San Francisco, United States of America

5Department of Obstetrics, Gynecology & Reproductive Sciences, UCSF, San Francisco, United States of America

6Department of Epidemiology and Biostatistics, UCSF, San Francisco, United States of America

Find articles by Song, Y. in: PubMed | Google Scholar

1Division of Reproductive Endocrinology & Infertility, Department of Obstetr, UCSF, San Francisco, United States of America

2CoLabs, UCSF, San Francisco, United States of America

3Center for Reproductive Sciences, UCSF, San Francisco, United States of America

4Bakar Computational Health Sciences Institute, UCSF, San Francisco, United States of America

5Department of Obstetrics, Gynecology & Reproductive Sciences, UCSF, San Francisco, United States of America

6Department of Epidemiology and Biostatistics, UCSF, San Francisco, United States of America

Find articles by Rabara, F. in: PubMed | Google Scholar

1Division of Reproductive Endocrinology & Infertility, Department of Obstetr, UCSF, San Francisco, United States of America

2CoLabs, UCSF, San Francisco, United States of America

3Center for Reproductive Sciences, UCSF, San Francisco, United States of America

4Bakar Computational Health Sciences Institute, UCSF, San Francisco, United States of America

5Department of Obstetrics, Gynecology & Reproductive Sciences, UCSF, San Francisco, United States of America

6Department of Epidemiology and Biostatistics, UCSF, San Francisco, United States of America

Find articles by Wong, R. in: PubMed | Google Scholar

1Division of Reproductive Endocrinology & Infertility, Department of Obstetr, UCSF, San Francisco, United States of America

2CoLabs, UCSF, San Francisco, United States of America

3Center for Reproductive Sciences, UCSF, San Francisco, United States of America

4Bakar Computational Health Sciences Institute, UCSF, San Francisco, United States of America

5Department of Obstetrics, Gynecology & Reproductive Sciences, UCSF, San Francisco, United States of America

6Department of Epidemiology and Biostatistics, UCSF, San Francisco, United States of America

Find articles by Zablotska, L. in: PubMed | Google Scholar

1Division of Reproductive Endocrinology & Infertility, Department of Obstetr, UCSF, San Francisco, United States of America

2CoLabs, UCSF, San Francisco, United States of America

3Center for Reproductive Sciences, UCSF, San Francisco, United States of America

4Bakar Computational Health Sciences Institute, UCSF, San Francisco, United States of America

5Department of Obstetrics, Gynecology & Reproductive Sciences, UCSF, San Francisco, United States of America

6Department of Epidemiology and Biostatistics, UCSF, San Francisco, United States of America

Find articles by Rosen, M. in: PubMed | Google Scholar

1Division of Reproductive Endocrinology & Infertility, Department of Obstetr, UCSF, San Francisco, United States of America

2CoLabs, UCSF, San Francisco, United States of America

3Center for Reproductive Sciences, UCSF, San Francisco, United States of America

4Bakar Computational Health Sciences Institute, UCSF, San Francisco, United States of America

5Department of Obstetrics, Gynecology & Reproductive Sciences, UCSF, San Francisco, United States of America

6Department of Epidemiology and Biostatistics, UCSF, San Francisco, United States of America

Find articles by Wittmann, T. in: PubMed | Google Scholar

1Division of Reproductive Endocrinology & Infertility, Department of Obstetr, UCSF, San Francisco, United States of America

2CoLabs, UCSF, San Francisco, United States of America

3Center for Reproductive Sciences, UCSF, San Francisco, United States of America

4Bakar Computational Health Sciences Institute, UCSF, San Francisco, United States of America

5Department of Obstetrics, Gynecology & Reproductive Sciences, UCSF, San Francisco, United States of America

6Department of Epidemiology and Biostatistics, UCSF, San Francisco, United States of America

Find articles by Fragiadakis, G. in: PubMed | Google Scholar |

1Division of Reproductive Endocrinology & Infertility, Department of Obstetr, UCSF, San Francisco, United States of America

2CoLabs, UCSF, San Francisco, United States of America

3Center for Reproductive Sciences, UCSF, San Francisco, United States of America

4Bakar Computational Health Sciences Institute, UCSF, San Francisco, United States of America

5Department of Obstetrics, Gynecology & Reproductive Sciences, UCSF, San Francisco, United States of America

6Department of Epidemiology and Biostatistics, UCSF, San Francisco, United States of America

Find articles by Combes, A. in: PubMed | Google Scholar |

1Division of Reproductive Endocrinology & Infertility, Department of Obstetr, UCSF, San Francisco, United States of America

2CoLabs, UCSF, San Francisco, United States of America

3Center for Reproductive Sciences, UCSF, San Francisco, United States of America

4Bakar Computational Health Sciences Institute, UCSF, San Francisco, United States of America

5Department of Obstetrics, Gynecology & Reproductive Sciences, UCSF, San Francisco, United States of America

6Department of Epidemiology and Biostatistics, UCSF, San Francisco, United States of America

Find articles by Sirota, M. in: PubMed | Google Scholar |

1Division of Reproductive Endocrinology & Infertility, Department of Obstetr, UCSF, San Francisco, United States of America

2CoLabs, UCSF, San Francisco, United States of America

3Center for Reproductive Sciences, UCSF, San Francisco, United States of America

4Bakar Computational Health Sciences Institute, UCSF, San Francisco, United States of America

5Department of Obstetrics, Gynecology & Reproductive Sciences, UCSF, San Francisco, United States of America

6Department of Epidemiology and Biostatistics, UCSF, San Francisco, United States of America

Find articles by Cedars, M. in: PubMed | Google Scholar

1Division of Reproductive Endocrinology & Infertility, Department of Obstetr, UCSF, San Francisco, United States of America

2CoLabs, UCSF, San Francisco, United States of America

3Center for Reproductive Sciences, UCSF, San Francisco, United States of America

4Bakar Computational Health Sciences Institute, UCSF, San Francisco, United States of America

5Department of Obstetrics, Gynecology & Reproductive Sciences, UCSF, San Francisco, United States of America

6Department of Epidemiology and Biostatistics, UCSF, San Francisco, United States of America

Find articles by Giudice, L. in: PubMed | Google Scholar

Published June 23, 2026 - More info

JCI Insight. https://doi.org/10.1172/jci.insight.202443.
Copyright © 2026, Huang et al. This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Published June 23, 2026 - Version history
View PDF
Abstract

BACKGROUND. In vitro fertilization (IVF) culminates in embryo transfer into a hormonally primed endometrium, often via a programmed cycle (PC) regimen postulated to influence hypertensive disorders of pregnancy (HDP) risk. We thus generated a single-cell atlas of PC endometrium to define cell type-specific differences relative to natural cycle (NC) endometrium, and evaluated whether PC-associated modulation of the window of implantation (WOI) endometrium influences angiogenic balance in pregnancy.

METHODS. Single-nucleus RNA-seq of prospectively collected PC and NC WOI endometrium. An independent prospective cohort of 548 singleton pregnancies was separately analyzed for maternal serum angiogenic markers (soluble fms-like tyrosine kinase-1; placental growth factor) and HDP incidence in PC- versus NC-conceived pregnancies, adjusting for clinical confounders and IVF use.

RESULTS. Prominent transcriptomic differences were observed between PC (n = 7; 48,843 nuclei) and NC (n = 9; 44,230 nuclei) WOI endometrium, particularly in glandular epithelium (682 up- and 979 down-regulated genes; adjusted P < 0.05) and stromal fibroblasts (108 up- and 168 down-regulated). PC endometrium showed reduced uterine natural killer cell abundance, potentially from CXCL14 downregulation. Functional enrichment revealed downregulation of embryo implantation, angiogenesis, and extracellular matrix remodeling pathways in PC. Altered cell-cell signaling in decidualization, angiogenesis, and inflammatory response was also observed. Despite these WOI perturbations, PC-conceived pregnancies were not associated with early gestational angiogenic imbalance or increased HDP risk.

CONCLUSION. PC endometrial preparation induced distinct cellular and signaling alterations in the WOI, but was not associated with subsequent development of angiogenic imbalance or HDP, thereby underscoring the resilience and adaptability of the early maternal-fetal interface.

TRIAL REGISTRATION. ClinicalTrials.gov NCT03799107.

FUNDING. ABOG/AAOGF; NICHD-R01-HD084380; NCTRI-P50-HD055764; NIAMS-P30-AR070155.

Supplemental material

View

Version history
  • Version 1 (June 23, 2026): In-Press Preview

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Supplemental material
  • Version history
Advertisement
Advertisement

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts